Photodynamic Therapy in Adolescents Halitosis
Primary Purpose
Halitosis
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
PDT
Tongue Scraper
Sponsored by
About this trial
This is an interventional treatment trial for Halitosis focused on measuring Halitosis,, Photodynamic Therapy,, Adolescent
Eligibility Criteria
Inclusion Criteria:
- Signed statement of informed consent;
- Authorization by legal guardian for the diagnosis and treatment of halitosis (Appendix 2);
- Halitosis score using cysteine: S2H ≥ 112 ppb and/or CH3SH ≥ 26 ppb (Oral ChromaTM).
Exclusion Criteria:
- Dental-facial anomalies;
- Currently undergoing orthodontic and/or orthopedic treatment;
- Use of removable appliance, implant or denture;
- Periodontal disease;
- Teeth with carious lesions;
- Currently undergoing cancer treatment;
- History of antibiotic treatment in previous month;
- Pregnancy;
- Hypersensitivity to the photosensitizing agent employed.
Sites / Locations
- Universidade Nove de JulhoRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Active Comparator
Experimental
Experimental
Experimental
Experimental
Arm Label
Group 1
Group 2
Group 4
Group 3
Group 5
Arm Description
Treatment with a tongue scraper
PDT wavelength = 660 nm Fluency = 320 J/cm2 Power = 100 milliwatt Energy = 9 J Time = 90 s
Tongue scraper + PDT wavelength = 660 nm Fluency = 320 J/cm2 Power = 100 milliwatt Energy = 9 J Time = 90 s
PDT wavelength = 660 nm Fluency = 428 J/cm2 Power = 100 milliwatt Energy = 12 J Time = 120 s
Tongue scraper + PDT wavelength = 660 nm Fluency = 428 J/cm2 Power = 100 milliwatt Energy = 12 J Time = 120 s
Outcomes
Primary Outcome Measures
Halitosis Scores
It will be compare de score of voalitile sulfur compounds in parts per billion (ppb) of hydrogen sulfide (H2S) and methyl mercaptan (CH3SH3).
Secondary Outcome Measures
Microbiological Analysis
Microbiological analyses of coated tongue will be performed before and after treatment using a 1-μl inoculation loop for the collection of biofilm samples from the dorsum of the tongue. The samples will be transferred to 1.5-ml vials with reduced transport fluid and placed in a vortex mixer for approximately 30 seconds for homogenization. Ten-fold serial dilution will be prepared in 180 μl of sterile phosphate buffered saline and aliquots of 10-2, 10-3, 10-4 and 10-5 will be transferred to plates with brain heart infusion agar. As the main bacteria responsible for the production of VSCs are Gram-negative, the plates will be incubated in anaerobic jar for 72 h at 37 °C, following by the quantification of colony-forming units (CFUs)
Full Information
NCT ID
NCT02007993
First Posted
November 26, 2013
Last Updated
July 31, 2014
Sponsor
University of Nove de Julho
1. Study Identification
Unique Protocol Identification Number
NCT02007993
Brief Title
Photodynamic Therapy in Adolescents Halitosis
Official Title
Photodynamic Therapy as Novel Treatment for Halitosis in Adolescents: Crontolled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2013
Overall Recruitment Status
Unknown status
Study Start Date
November 2013 (undefined)
Primary Completion Date
September 2014 (Anticipated)
Study Completion Date
October 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Nove de Julho
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the proposed controlled clinical trial is to evaluate the effect of photodynamic therapy (PDT) on the formation of volatile sulfur compounds (VSCs) from coated tongue and its action on the severity of halitosis in adolescents using different treatment protocols.
HYPOTHESIS
- Null hypothesis: There is no change in halitosis following the use of photodynamic therapy.
- Experimental hypothesis: There is a reduction in halitosis following the use of photodynamic therapy alone or in combination with a tongue scraper.
Detailed Description
Halitosis (bad breath) is a term used to describe an unpleasant odor emanating from the mouth that could originate in the oral cavity itself or as a result of systemic factors. Halitosis is a common problem that affects most of the population worldwide and is caused mainly by the volatile sulfur compounds produced by anaerobic Gram-negative microorganisms in the oral cavity on sulfur-containing substrates in the oral cavity. On the dorsum of the tongue, the volatile sulfur compounds produced from this metabolism are hydrogen sulfide (H2S), methyl mercaptan (CH3SH3) and dimethyl sulfide (CH3-S-CH3). The concentration of these gases is used as an indicator of the severity of halitosis. Recently, the Gram positive anaerobic bacterium Solobacterium moorei (formerly known as Bulleidia moorei) has also been associated with oral malodor by volatile sulfur compounds production, particularly hydrogen sulfide in the presence of different supplements with amino acids more specifically cysteine, wich agrees with studies showing that the cysteine challenge is a in vivo and in vitro model for analyzing the production of hydrogen sulfide.
The measure of volatile sulfur compounds can be performed by an organoleptic evaluation of the air emanating from the oral cavity through gas chromatography or the use of a sulfide monitor, such at the Halimeter (Interscan Corporation), which determines the amount of volatile sulfur compounds in parts per billion (ppb) in the exhaled air. Gas chromatography is the most appropriate means for detecting halitosis of different origins. In 2004, the Oral ChromaTM (Abilit Corporation) was developed in Japan for the individual measurement of the three main gases (hydrogen sulfide, methyl mercaptan and dimethyl sulfide), allowing the evaluation of the intensity and origin of halitosis.
Light, either alone or in combination with chemical compounds, has been used for its therapeutic and antimicrobial effects. Photodynamic therapy encompasses the simultaneous action of a light source and photosensitizing agent in the presence of oxygen in tissues. Individually, each of these substances is innocuous, but their interaction is capable of giving rise to cytotoxic species that lead to cell death.The advantage of this approach is the avoidance of the development of resistance on the part of the target bacteria and damage to the adjacent tissues, since the antimicrobial effect is confined to the area covered by the dye and irradiated by the light, acting quickly on the target organisms. The efficacy of photodynamic therapy depends on the energy dose and output power employed.
Evaluation of degree of halitosis:
The portable Oral ChromaTM device (Abilit, Japan) will be employed. This device uses a highly sensitive gas semiconductor sensor.It will be connected to the computer with a specific software program that allows the creation of a graph corresponding to the peaks and concentrations of gases, measuring the VSC thresholds (0 to 1000 ppb), with considerable precision after eight minutes.
Analysis of volatile sulfur compounds:
Hydrogen sulfide: values greater than 112 ppb indicate halitosis (SH2 ≥ 112 ppb);
Methyl mercaptan: values greater than 26 ppb indicate halitosis (CH3SH ≥ 26 ppb);
A quantitative, controlled, cross-sectional, clinical trial will be carried out involving 130 teenagers. All individuals will be submitted to evaluations with Oral ChromaTM for the diagnosis of halitosis (scores SH2 ≥ 112 ppb and CH3SH ≥ 26 ppb) at the beginning of the study. Three post-treatment evaluations will be carried out: one hour, 24 hours and one week after treatment. The subjects selected will be randomly allocated to five groups:
Group 1 will receive treatment with a tongue scraper;
Group 2 and 3will receive photodynamic therapy applied to the posterior two thirds of the dorsum of the tongue;
Groups 4 and 5 will receive combined treatment (tongue scraper and photodynamic therapy).
The statistical analysis will include the chi-square test and Fisher's Exact Test. The Student's t-test and analysis of variance (ANOVA) will be used for the comparison of means. Pearson's correlation coefficients will be calculated to determine the strength of correlations between continuous variables. A 95% significance level will be considered on all statistical tests (p < 0.05).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Halitosis
Keywords
Halitosis,, Photodynamic Therapy,, Adolescent
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 1
Arm Type
Active Comparator
Arm Description
Treatment with a tongue scraper
Arm Title
Group 2
Arm Type
Experimental
Arm Description
PDT wavelength = 660 nm Fluency = 320 J/cm2 Power = 100 milliwatt Energy = 9 J Time = 90 s
Arm Title
Group 4
Arm Type
Experimental
Arm Description
Tongue scraper + PDT wavelength = 660 nm Fluency = 320 J/cm2 Power = 100 milliwatt Energy = 9 J Time = 90 s
Arm Title
Group 3
Arm Type
Experimental
Arm Description
PDT wavelength = 660 nm Fluency = 428 J/cm2 Power = 100 milliwatt Energy = 12 J Time = 120 s
Arm Title
Group 5
Arm Type
Experimental
Arm Description
Tongue scraper + PDT wavelength = 660 nm Fluency = 428 J/cm2 Power = 100 milliwatt Energy = 12 J Time = 120 s
Intervention Type
Other
Intervention Name(s)
PDT
Intervention Description
A single session of PDT will be performed with the Chimiolux® photosensitizer at a concentration of 0.005% applied over the middle and posterior thirds of the dorsum of the tongue.
Nine points will be irradiated, the device will be previously calibrated with a wavelength of 660 nm, power of 100 mW, energy of 9 joules for 90 seconds per point in Groups 2 and 4 and 12 joules for 120 second per point in Groups 3 and 5
Intervention Type
Other
Intervention Name(s)
Tongue Scraper
Intervention Description
The pacient will scrap the tongue 10 times.
Primary Outcome Measure Information:
Title
Halitosis Scores
Description
It will be compare de score of voalitile sulfur compounds in parts per billion (ppb) of hydrogen sulfide (H2S) and methyl mercaptan (CH3SH3).
Time Frame
Prior to the initial photodynamic therapy on day 1 and 1, 24 and 168 hours post-photodynamic therapy
Secondary Outcome Measure Information:
Title
Microbiological Analysis
Description
Microbiological analyses of coated tongue will be performed before and after treatment using a 1-μl inoculation loop for the collection of biofilm samples from the dorsum of the tongue. The samples will be transferred to 1.5-ml vials with reduced transport fluid and placed in a vortex mixer for approximately 30 seconds for homogenization. Ten-fold serial dilution will be prepared in 180 μl of sterile phosphate buffered saline and aliquots of 10-2, 10-3, 10-4 and 10-5 will be transferred to plates with brain heart infusion agar. As the main bacteria responsible for the production of VSCs are Gram-negative, the plates will be incubated in anaerobic jar for 72 h at 37 °C, following by the quantification of colony-forming units (CFUs)
Time Frame
Prior to the initial photodynamic therapy on day 1 and 1 and 24 hours post-photodynamic therapy
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Signed statement of informed consent;
Authorization by legal guardian for the diagnosis and treatment of halitosis (Appendix 2);
Halitosis score using cysteine: S2H ≥ 112 ppb and/or CH3SH ≥ 26 ppb (Oral ChromaTM).
Exclusion Criteria:
Dental-facial anomalies;
Currently undergoing orthodontic and/or orthopedic treatment;
Use of removable appliance, implant or denture;
Periodontal disease;
Teeth with carious lesions;
Currently undergoing cancer treatment;
History of antibiotic treatment in previous month;
Pregnancy;
Hypersensitivity to the photosensitizing agent employed.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rubia G Lopes, master
Phone
55 11 985939878
Email
rubia.lopes.rl@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Sandra K Bussadori, phd
Email
sandra.skb@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sandra K Bussadori, phd
Organizational Affiliation
University of Nove de Julho
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Rubia G Lopes, master
Organizational Affiliation
University of Nove de Julho
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universidade Nove de Julho
City
SP
ZIP/Postal Code
01504-001
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rubia G Lopes, master
Phone
551130782797
Email
rubia.lopes.rl@gmail.com
First Name & Middle Initial & Last Name & Degree
Rubia G Lopes, master
12. IPD Sharing Statement
Citations:
PubMed Identifier
27248838
Citation
Costa da Mota AC, Franca CM, Prates R, Deana AM, Costa Santos L, Lopes Garcia R, Leal Goncalves ML, Mesquita Ferrari RA, Porta Santos Fernandes K, Kalil Bussadori S. Effect of photodynamic therapy for the treatment of halitosis in adolescents - a controlled, microbiological, clinical trial. J Biophotonics. 2016 Dec;9(11-12):1337-1343. doi: 10.1002/jbio.201600067. Epub 2016 Jun 1.
Results Reference
derived
PubMed Identifier
26510574
Citation
Lopes RG, da Mota AC, Soares C, Tarzia O, Deana AM, Prates RA, Franca CM, Fernandes KP, Ferrari RA, Bussadori SK. Immediate results of photodynamic therapy for the treatment of halitosis in adolescents: a randomized, controlled, clinical trial. Lasers Med Sci. 2016 Jan;31(1):41-7. doi: 10.1007/s10103-015-1822-6. Epub 2015 Oct 28.
Results Reference
derived
PubMed Identifier
25394474
Citation
Lopes RG, de Godoy CH, Deana AM, de Santi ME, Prates RA, Franca CM, Fernandes KP, Mesquita-Ferrari RA, Bussadori SK. Photodynamic therapy as a novel treatment for halitosis in adolescents: study protocol for a randomized controlled trial. Trials. 2014 Nov 14;15:443. doi: 10.1186/1745-6215-15-443.
Results Reference
derived
Learn more about this trial
Photodynamic Therapy in Adolescents Halitosis
We'll reach out to this number within 24 hrs